Recent Finacing
Recent Raise
Calidi Biotherapeutics is a clinical-stage immuno-oncology company developing allogeneic stem-cell–based delivery platforms that house, protect, and potentiate oncolytic viruses (e.g., SNV1c) for multiple cancer indications.
